1,537
Participants
Start Date
March 9, 2017
Primary Completion Date
December 30, 2017
Study Completion Date
December 30, 2017
No Treatment
No treatment
Peking University Shougang Hospital, Beijing
Shengjing Hospital of China Medical University, Shenyang
First Affiliated Hospital of Dalian Medical University, Dalian
Nanjing First Hospital, Nanjing
Integrated Chinese and Western Medicine Hospital, Nanjing
The First Affiliated Hospital of Soochow University, Suzhou
The First Affiliated Hospital of Anhui Medical University, Hefei
The affiliated hospital of medicalcollege qingdao university, Qingdao
Shenzhen People's Hospital, Shenzhen
Chinese Traditional Medicine Hospital of Sichuna Provinc, Chengdu
West China Hospital, Chengdu
Beijing Hospital, Beijing
Beijing Pinggu Hospital, Beijing
China Meitan General Hospital, Beijing
First Hospital of Jilin University, Changchun
Forth Clinical Hospital of Harbin Medical University, Harbin
The First Affiliated Hospital of Henan University of Science and Technology, Luoyang
Affiliated Hospital of Nantong University, Nantong
Lead Sponsor
Boehringer Ingelheim
INDUSTRY